Although we do not claim superiority of the IVDST based on the available data, our findings indicate it is a reliable outpatient-based second-line diagnostic test to distinguish CS from non-CS, particularly given the ongoing shortage of CRH. The gene discussed is CRH; the disease is Cowden syndrome 1.